He Huang

21.9k total citations · 7 hit papers
576 papers, 10.5k citations indexed

About

He Huang is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, He Huang has authored 576 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 211 papers in Oncology, 206 papers in Molecular Biology and 184 papers in Hematology. Recurrent topics in He Huang's work include CAR-T cell therapy research (143 papers), Hematopoietic Stem Cell Transplantation (116 papers) and Acute Myeloid Leukemia Research (68 papers). He Huang is often cited by papers focused on CAR-T cell therapy research (143 papers), Hematopoietic Stem Cell Transplantation (116 papers) and Acute Myeloid Leukemia Research (68 papers). He Huang collaborates with scholars based in China, United States and France. He Huang's co-authors include Pengxu Qian, Yongxian Hu, Yi Luo, Yanmin Zhao, Xia Li, Jimin Shi, Chentao Li, Wanying Zhang, Yanan Wang and Yongxian Hu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

He Huang

530 papers receiving 10.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammation and aging: signaling pathways and intervention therapies

2023 674 citations Xia Li, Pengxu Qian et al. profile →
Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte

2019 289 citations He Huang et al. profile →
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

2021 202 citations Yongxian Hu, Guoqing Wei et al. profile →
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

2021 150 citations He Huang et al. profile →
Acute graft-versus-host disease

2023 100 citations He Huang et al. profile →
Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation

2023 96 citations Xiangjun Zeng, Xiaoqing Li et al. Blood profile →
Microplastics dampen the self-renewal of hematopoietic stem cells by disrupting the gut microbiota-hypoxanthine-Wnt axis

2024 42 citations Yingli Han, Jimin Shi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
He Huang China	50	4.3k	3.0k	2.3k	2.0k	938	576	10.5k
Zwi Berneman Belgium	53	4.8k 1.1×	3.7k 1.2×	2.3k 1.0×	4.6k 2.3×	1.5k 1.6×	320	13.2k
Jianxiang Wang China	42	3.8k 0.9×	2.1k 0.7×	2.8k 1.2×	1.1k 0.6×	1.1k 1.2×	415	7.7k
Sergio Rutella Italy	47	2.3k 0.6×	2.0k 0.7×	2.3k 1.0×	3.0k 1.5×	1.1k 1.2×	239	8.2k
Sharon A. Savage United States	54	5.7k 1.3×	1.9k 0.6×	1.1k 0.5×	1.0k 0.5×	776 0.8×	245	11.6k
Kevin Shannon United States	58	6.2k 1.5×	2.2k 0.7×	3.7k 1.6×	1.6k 0.8×	1.7k 1.8×	276	12.5k
Jie Jin China	43	4.0k 0.9×	1.5k 0.5×	2.4k 1.0×	780 0.4×	1.2k 1.3×	593	8.5k
Janice Gabrilove United States	41	4.3k 1.0×	3.3k 1.1×	4.6k 2.0×	2.0k 1.0×	1.2k 1.3×	148	11.0k
Gerrit Jansen Netherlands	58	5.1k 1.2×	3.9k 1.3×	1.7k 0.7×	769 0.4×	549 0.6×	330	11.4k
Naoyuki Kamatani Japan	58	5.3k 1.2×	2.1k 0.7×	1.3k 0.6×	2.5k 1.2×	759 0.8×	344	13.5k
Farzin Farzaneh United Kingdom	45	4.4k 1.0×	1.7k 0.6×	2.4k 1.0×	1.9k 0.9×	1.2k 1.3×	215	9.6k

Countries citing papers authored by He Huang

Since Specialization

Citations

This map shows the geographic impact of He Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Huang more than expected).

Fields of papers citing papers by He Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Huang. The network helps show where He Huang may publish in the future.

Co-authorship network of co-authors of He Huang

This figure shows the co-authorship network connecting the top 25 collaborators of He Huang. A scholar is included among the top collaborators of He Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He Huang. He Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Han, Yijin Chen, Houli Zhao, et al.. (2025). Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective study. Bone Marrow Transplantation. 60(5). 587–594.

Shi, Rui, et al.. (2024). A Case Report of Urinary Tract Infection and Fungemia Due to Pichia ohmeri Complicated with Pulmonary Thromboembolism. Infection and Drug Resistance. Volume 17. 11–15. 1 indexed citations

Li, Zhenhao, Zhian Chen, Yutong Wang, et al.. (2024). Icariside I enhances the effects of immunotherapy in gastrointestinal cancer via targeting TRPV4 and upregulating the cGAS-STING-IFN-I pathway. Biomedicine & Pharmacotherapy. 177. 117134–117134. 3 indexed citations

Li, Chunrui, Dehui Zou, He Huang, et al.. (2024). Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study. Blood. 144(Supplement 1). 4761–4761. 2 indexed citations

Huang, He, et al.. (2024). Identification of potential biomarkers and pathways involved in high-altitude pulmonary edema using GC-MS and LC-MS metabolomic methods. Scientific Reports. 14(1). 30978–30978. 1 indexed citations

Liang, Rongpu, Dongbing Ding, Shengxin Huang, et al.. (2024). HDACi combination therapy with IDO1i remodels the tumor microenvironment and boosts antitumor efficacy in colorectal cancer with microsatellite stability. Journal of Nanobiotechnology. 22(1). 753–753. 5 indexed citations

Zhang, Huang, Yilin Zhang, He Huang, et al.. (2023). Identification for meat adulteration (pork, beef, sheep and duck) in foodstuff by microfluidic chip-based real-time fluorescent LAMP. Journal of Food Composition and Analysis. 119. 105223–105223. 13 indexed citations

Tan, Siew Har, et al.. (2023). Phenotyping Diabetes Mellitus on Aggregated Electronic Health Records from Disparate Health Systems. SHILAP Revista de lepidopterología. 2(3). 223–235.

Zheng, Gaofeng, et al.. (2023). Follicular helper T cells: emerging roles in lymphomagenesis. Journal of Leukocyte Biology. 116(1). 54–63. 1 indexed citations

10.

Zeng, Xiangjun, Xiaoqing Li, Xia Li, et al.. (2023). Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation. Blood. 141(14). 1691–1707. 96 indexed citations breakdown →

11.

Wei, Guoqing, Yanlei Zhang, Houli Zhao, et al.. (2021). CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study. Cancer Immunology Research. 9(9). 1061–1070. 47 indexed citations

12.

Wudhikarn, Kitsada, Shui Yen Soh, He Huang, & Miguel‐Angel Perales. (2021). Toxicity of Chimeric Antigen Receptor T Cells and its Management. PubMed. 4(Special Edition). S1–S7. 5 indexed citations

13.

D, Li, Wenjian Liao, He Huang, et al.. (2020). Emergence of Hypervirulent Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Isolates in a Chinese Tertiary Hospital. SHILAP Revista de lepidopterología.

14.

Zhang, Ye, et al.. (2020). LncRNA FEZF1-AS1 Sponges miR-34a to Upregulate Notch-1 in Glioblastoma. SHILAP Revista de lepidopterología. 1 indexed citations

15.

Huang, He, Bo Wang, Guohai Xu, et al.. (2020). Copper Oxide Nanoparticles Induce Oxidative DNA Damage and Cell Death via Copper Ion-Mediated P38 MAPK Activation in Vascular Endothelial Cells. SHILAP Revista de lepidopterología. 1 indexed citations

16.

Wang, Boshi, Chao Shen, Li Y, et al.. (2019). Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling. SHILAP Revista de lepidopterología. 3 indexed citations

17.

Huang, He, Lu Cai, Wu Zhang, et al.. (2019). Antibacterial and osteogenesis performances of LL37-loaded titania nanopores in vitro and in vivo. SHILAP Revista de lepidopterología. 1 indexed citations

18.

Li, Xue, Xianwen Meng, Wei Cong, et al.. (2018). Dissecting LncRNA Roles in Renal Cell Carcinoma Metastasis and Characterizing Genomic Heterogeneity by Single-Cell RNA-seq. Molecular Cancer Research. 16(12). 1879–1888. 21 indexed citations

19.

Luo, Yi, Haowen Xiao, Xiaoyu Lai, et al.. (2014). T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood. 124(17). 2735–2743. 139 indexed citations

20.

Zhang, Lifei, Weiyan Zheng, Yebo Wang, Yingjia Wang, & He Huang. (2013). Human Bone Marrow Mesenchymal Stem Cells Support the Derivation and Propagation of Human Induced Pluripotent Stem Cells in Culture. Cellular Reprogramming. 15(3). 216–223. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact